Article Versions Notes

Patel A, Tong S, Lozada K, Awasthi A, Silverman RB, Totonchy J, Yang S. Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors. Pharmaceutics. 2025; 17(6):691. https://doi.org/10.3390/pharmaceutics17060691

Patel, Anika, Shirley Tong, Kate Lozada, Amardeep Awasthi, Richard B. Silverman, Jennifer Totonchy, and Sun Yang. 2025. "Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors" Pharmaceutics 17, no. 6: 691. https://doi.org/10.3390/pharmaceutics17060691

Patel, A., Tong, S., Lozada, K., Awasthi, A., Silverman, R. B., Totonchy, J., & Yang, S. (2025). Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors. Pharmaceutics, 17(6), 691. https://doi.org/10.3390/pharmaceutics17060691